Hit enter to search or ESC to close
MaaT Pharma
  • About us
  • Technology
  • Pipeline
  • News
  • Contact
  • Investors
MaaT Pharma
Business Update

MaaT Pharma Appoints Claude Bertrand, Servier’s Executive Vice President of R&D, as Independent Board Member and Welcomes New Chief Medical Officer John Weinberg

Lyon, France, July 16, 2020 – MaaT Pharma announced today the appointment of Claude Bertrand,…
MaaT Pharma
MaaT PharmaJuly 16, 2020
Press Releases

MaaT Pharma Appoints Savita Bernal as Chief Business Officer

Lyon, France, May 28, 2020 – MaaT Pharma announced today that Savita Bernal, PhD, has…
MaaT Pharma
MaaT PharmaMay 28, 2020
Press Releases

MaaT Pharma Announces Formation of Its GvHD-focused Scientific Advisory Board to Support Development of Microbiome Restoration Therapeutics in Hemato-oncological Indications

Lyon, France, May 12, 2020 – MaaT Pharma announced today the appointment of leading international…
nboutaoui
nboutaouiMay 12, 2020
Business Update

PR FDA Safety Alert

In response to the recent “FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation…
nboutaoui
nboutaouiMarch 13, 2020
Business Update

MaaT Pharma – Information COVID-19

March 13th, 2020   MaaT Pharma – Information COVID-19 In the context of the COVID-19…
nboutaoui
nboutaouiMarch 13, 2020
Business Update

MaaT Pharma – Information COVID-19

Le 13 mars 2020   MaaT Pharma - Information covid 19   Dans le cadre…
nboutaoui
nboutaouiMarch 13, 2020
Press Releases

MaaT Pharma Annonce 18 millions d’euros de Financement Série B pour l’Expansion de son Développement Clinique de Médicaments Biologiques « Microbiote »

Lyon, le 5 février 2020 - MaaT Pharma annonce aujourd'hui une levée de fonds de…
nboutaoui
nboutaouiFebruary 4, 2020
Press Releases

MaaT Pharma Announces €18 Million Series B Financing Round to Support Further Clinical Development of Microbiome Biotherapeutics

Lyon, France, February 5, 2020 – MaaT Pharma announced today an €18 million Series B…
nboutaoui
nboutaouiJanuary 31, 2020
Posters

Posters – ASH 2019

nboutaoui
nboutaouiDecember 7, 2019
Press Releases

MaaT Pharma announces the presentation of data with its Lead Microbiota Biotherapeutic in intestinal GvHD at 61st American Society of Hematology (ASH) Annual Meeting

  Lyon, France, November 6, 2019 – MaaT Pharma announced today that a poster will…
nboutaoui
nboutaouiNovember 6, 2019
NextPrevious »

Categories

  • Business Update (6)
  • Media (12)
  • Posters (8)
  • Press Releases (35)

MAAT PHARMA

  • Legal
  • Careers

COMPANY

  • Home
  • About Us
  • Technology
  • Pipeline
  • Partnership

RESSOURCES

  • News
  • Playing Cards

CONTACT

  • Contact Us
  • Twitter
  • Facebook
  • Linkedin

© 2020 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases

  • About us
  • Technology
  • Pipeline
  • News
  • Contact
  • Investors